Global Opioid Use Disorder Treatment Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Naloxone, Buprenorphine, and Methadone), By Sales Channel (Retail Pharmacies, Hospitals, Rehabilitation Centers), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

Industry: Healthcare
RELEASE DATE Jan 2024
REPORT ID SI3527
PAGES 200
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis, By Drug Class
      2. Market Attractiveness Analysis, By Sales Channel
      3. Market Attractiveness Analysis, By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Expanding treatment facilities and their mergers with private recovery organizations
    3. Restraints
      1.  Adoption of buprenorphine patches propelling market expansion
    4. Opportunities
      1.  The global opioid use disorder treatment market is being driven by a number of factors
    5. Challenges
      1. Side-effects from drug administration to restrain market expansion
  6. Global Opioid Use Disorder Treatment Market Analysis and Projection, By Drug Class
    1. Segment Overview
    2. Naloxone
    3. Buprenorphine
    4. Methadone
  7. Global Opioid Use Disorder Treatment Market Analysis and Projection, By Sales Channel
    1. Segment Overview
    2. Retail Pharmacies
    3. Hospitals
    4. Rehabilitation Centers
  8. Global Opioid Use Disorder Treatment Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global Opioid Use Disorder Treatment Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Opioid Use Disorder Treatment Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. Trevena
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Titan Pharmaceuticals, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  BioDelivery Sciences International Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Novartis AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Gamida-Cell
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Opiate Pharmaceutical
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Aphios
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Kyowa kirin
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Hikma Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  MediciNova
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Alkermes, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Opioid Use Disorder Treatment Market, By Drug Class, 2022-203(USD Billion)
  2. Global Naloxone, Opioid Use Disorder Treatment Market, By Region, 2022-2032(USD Billion)
  3. Global Buprenorphine, Opioid Use Disorder Treatment Market, By Region, 2022-2032(USD Billion)
  4. Global Methadone, Opioid Use Disorder Treatment Market, By Region, 2022-2032(USD Billion)
  5. Global Opioid Use Disorder Treatment Market, By Sales Channel, 2022-2032(USD Billion)
  6. Global Retail Pharmacies, Opioid Use Disorder Treatment Market, By Region, 2022-2032(USD Billion)
  7. Global Hospitals, Opioid Use Disorder Treatment Market, By Region, 2022-2032(USD Billion)
  8. Global Rehabilitation Centers, Opioid Use Disorder Treatment Market, By Region, 2022-2032(USD Billion)
  9. North America Opioid Use Disorder Treatment Market, By Drug Class, 2022-2032(USD Billion)
  10. North America Opioid Use Disorder Treatment Market, By Sales Channel, 2022-2032(USD Billion)
  11. U.S.  Opioid Use Disorder Treatment Market, By Drug Class, 2022-2032(USD Billion)
  12. U.S.  Opioid Use Disorder Treatment Market, By Sales Channel, 2022-2032(USD Billion)
  13. Canada Opioid Use Disorder Treatment Market, By Drug Class, 2022-2032(USD Billion)
  14. Canada Opioid Use Disorder Treatment Market, By Sales Channel, 2022-2032(USD Billion)
  15. Mexico Opioid Use Disorder Treatment Market, By Drug Class, 2022-2032(USD Billion)
  16. Mexico Opioid Use Disorder Treatment Market, By Sales Channel, 2022-2032(USD Billion)
  17. Europe Opioid Use Disorder Treatment Market, By Drug Class, 2022-2032(USD Billion)
  18. Europe Opioid Use Disorder Treatment Market, By Sales Channel, 2022-2032(USD Billion)
  19. Germany Opioid Use Disorder Treatment Market, By Drug Class, 2022-2032(USD Billion)
  20. Germany Opioid Use Disorder Treatment Market, By Sales Channel, 2022-2032(USD Billion)
  21. France Opioid Use Disorder Treatment Market, By Drug Class, 2022-2032(USD Billion)
  22. France Opioid Use Disorder Treatment Market, By Sales Channel, 2022-2032(USD Billion)
  23. U.K.  Opioid Use Disorder Treatment Market, By Drug Class, 2022-2032(USD Billion)
  24. U.K.  Opioid Use Disorder Treatment Market, By Sales Channel, 2022-2032(USD Billion)
  25. Italy Opioid Use Disorder Treatment Market, By Drug Class, 2022-2032(USD Billion)
  26. Italy Opioid Use Disorder Treatment Market, By Sales Channel, 2022-2032(USD Billion)
  27. Spain Opioid Use Disorder Treatment Market, By Drug Class, 2022-2032(USD Billion)
  28. Spain Opioid Use Disorder Treatment Market, By Sales Channel, 2022-2032(USD Billion)
  29. Asia Pacific Opioid Use Disorder Treatment Market, By Drug Class, 2022-2032(USD Billion)
  30. Asia Pacific Opioid Use Disorder Treatment Market, By Sales Channel, 2022-2032(USD Billion)
  31. Japan Opioid Use Disorder Treatment Market, By Drug Class, 2022-2032(USD Billion)
  32. Japan Opioid Use Disorder Treatment Market, By Sales Channel, 2022-2032(USD Billion)
  33. China Opioid Use Disorder Treatment Market, By Drug Class, 2022-2032(USD Billion)
  34. China Opioid Use Disorder Treatment Market, By Sales Channel, 2022-2032(USD Billion)
  35. India Opioid Use Disorder Treatment Market, By Drug Class, 2022-2032(USD Billion)
  36. India Opioid Use Disorder Treatment Market, By Sales Channel, 2022-2032(USD Billion)
  37. South America Opioid Use Disorder Treatment Market, By Drug Class, 2022-2032(USD Billion)
  38. South America Opioid Use Disorder Treatment Market, By Sales Channel, 2022-2032(USD Billion)
  39. Brazil Opioid Use Disorder Treatment Market, By Drug Class, 2022-2032(USD Billion)
  40. Brazil Opioid Use Disorder Treatment Market, By Sales Channel, 2022-2032(USD Billion)
  41. The Middle East and Africa Opioid Use Disorder Treatment Market, By Drug Class, 2022-2032(USD   Billion)
  42. The Middle East and Africa Opioid Use Disorder Treatment Market, By Sales Channel, 2022-2032(USD   Billion)
  43. UAE Opioid Use Disorder Treatment Market, By Drug Class, 2022-2032(USD Billion)
  44. UAE Opioid Use Disorder Treatment Market, By Sales Channel, 2022-2032(USD Billion)
  45. South Africa Opioid Use Disorder Treatment Market, By Drug Class, 2022-2032(USD Billion)
  46. South Africa Opioid Use Disorder Treatment Market, By Sales Channel, 2022-2032(USD Billion)

List of Figures 

  1. Global Opioid Use Disorder Treatment Market Segmentation
  2. Opioid Use Disorder Treatment Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Opioid Use Disorder Treatment Market
  9. Top Winning Strategies, 2022-2032
  10. Top Winning Strategies, By Development, 2022-2032(%)
  11. Top Winning Strategies, By Company, 2022-2032
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers:  Opioid Use Disorder Treatment Market
  20. Opioid Use Disorder Treatment Market Segmentation, By Drug Class
  21. Opioid Use Disorder Treatment Market For Naloxone, By Region, 2022-2032 ($ Billion)
  22.  Opioid Use Disorder Treatment Market For Buprenorphine, By Region, 2022-2032 ($ Billion)
  23. Opioid Use Disorder Treatment Market For Methadone, By Region, 2022-2032 ($ Billion)
  24.  Opioid Use Disorder Treatment Market Segmentation, By Sales Channel
  25.  Opioid Use Disorder Treatment Market For Retail Pharmacies, By Region, 2022-2032 ($ Billion)
  26.  Opioid Use Disorder Treatment Market For Hospitals, By Region, 2022-2032 ($ Billion)
  27. Opioid Use Disorder Treatment Market For Rehabilitation Centers, By Region, 2022-2032 ($ Billion)
  28. Trevena: Net Sales, 2022-2032 ($ Billion)
  29. Trevena: Revenue Share, By Segment, 2022 (%)
  30. Trevena: Revenue Share, By Region, 2022 (%)
  31. Titan Pharmaceuticals, Inc.: Net Sales, 2022-2032 ($ Billion)
  32. Titan Pharmaceuticals, Inc.: Revenue Share, By Segment, 2022 (%)
  33. Titan Pharmaceuticals, Inc.: Revenue Share, By Region, 2022 (%)
  34. BioDelivery Sciences International Inc.: Net Sales, 2022-2032 ($ Billion)
  35. BioDelivery Sciences International Inc.: Revenue Share, By Segment, 2022 (%)
  36. BioDelivery Sciences International Inc.: Revenue Share, By Region, 2022 (%)
  37. Novartis AG: Net Sales, 2022-2032 ($ Billion)
  38. Novartis AG: Revenue Share, By Segment, 2022 (%)
  39. Novartis AG: Revenue Share, By Region, 2022 (%)
  40. Gamida-Cell: Net Sales, 2022-2032 ($ Billion)
  41. Gamida-Cell: Revenue Share, By Segment, 2022 (%)
  42. Gamida-Cell: Revenue Share, By Region, 2022 (%)
  43. Opiate Pharmaceutical: Net Sales, 2022-2032 ($ Billion)
  44. Opiate Pharmaceutical: Revenue Share, By Segment, 2022 (%)
  45. Opiate Pharmaceutical: Revenue Share, By Region, 2022 (%)
  46. Aphios: Net Sales, 2022-2032 ($ Billion)
  47. Aphios: Revenue Share, By Segment, 2022 (%)
  48. Aphios: Revenue Share, By Region, 2022 (%)
  49. Kyowa kirin: Net Sales, 2022-2032 ($ Billion)
  50. Kyowa kirin: Revenue Share, By Segment, 2022 (%)
  51. Kyowa kirin: Revenue Share, By Region, 2022 (%)
  52. Hikma Pharmaceuticals.: Net Sales, 2022-2032 ($ Billion)
  53. Hikma Pharmaceuticals.: Revenue Share, By Segment, 2022 (%)
  54. Hikma Pharmaceuticals.: Revenue Share, By Region, 2022 (%)
  55. MediciNova: Net Sales, 2022-2032 ($ Billion)
  56. MediciNova: Revenue Share, By Segment, 2022 (%)
  57. MediciNova: Revenue Share, By Region, 2022 (%)
  58. Alkermes, Inc.: Net Sales, 2022-2032 ($ Billion)
  59. Alkermes, Inc.: Revenue Share, By Segment, 2022 (%)
  60. Alkermes, Inc.: Revenue Share, By Region, 2022 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:120
Pages:200
Countries covered:17
Companies covered::20
Forecast CAGR:11.52%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies